INTRODUCTION: Intracranial ependymomas (IE) in children are aggressive tumors, and total resection (TR) is considered to be the most powerful predictor of outcome. The data regarding recurrent IE (RIE), in particular the role of reoperation, are scarce in the literature. METHODS AND RESULTS: We studied 70 cases of IE in children operated on for IE since the advent of computed imaging. TR was achieved at initial surgery in 38 out of 70 cases. After a mean follow-up of 76.1 months, 33 out of 70 tumors had progressed. Eighteen were reoperated, achieving TR in 12 out of 18 cases. The morbidity associated with reoperation was minimal, especially compared with the first operation. After a mean follow-up of 74.7 months after reoperation, 10 out of 18 patients had died of tumor progression, 1 had a stable tumor, and 7 were tumor free. When TR was achieved, the overall survival rate was 7 out of 12. CONCLUSION: Total resection is the only curative treatment for RIE and is often possible, especially when the initial resection was total.
INTRODUCTION:Intracranial ependymomas (IE) in children are aggressive tumors, and total resection (TR) is considered to be the most powerful predictor of outcome. The data regarding recurrent IE (RIE), in particular the role of reoperation, are scarce in the literature. METHODS AND RESULTS: We studied 70 cases of IE in children operated on for IE since the advent of computed imaging. TR was achieved at initial surgery in 38 out of 70 cases. After a mean follow-up of 76.1 months, 33 out of 70 tumors had progressed. Eighteen were reoperated, achieving TR in 12 out of 18 cases. The morbidity associated with reoperation was minimal, especially compared with the first operation. After a mean follow-up of 74.7 months after reoperation, 10 out of 18 patients had died of tumor progression, 1 had a stable tumor, and 7 were tumor free. When TR was achieved, the overall survival rate was 7 out of 12. CONCLUSION: Total resection is the only curative treatment for RIE and is often possible, especially when the initial resection was total.
Authors: Marie-Lise C van Veelen-Vincent; Alain Pierre-Kahn; Chantale Kalifa; Christian Sainte-Rose; Michel Zerah; John Thorne; Dominique Renier Journal: J Neurosurg Date: 2002-10 Impact factor: 5.115
Authors: G Perilongo; M Massimino; G Sotti; T Belfontali; L Masiero; L Rigobello; L Garrè; M Carli; F Lombardi; C Solero; L Sainati; V Canale; A B del Prever; F Giangaspero; L Andreussi; C Mazza; E Madon Journal: Med Pediatr Oncol Date: 1997-08
Authors: M P McLaughlin; R B Marcus; J M Buatti; W M McCollough; J P Mickle; A Kedar; B L Maria; R R Million Journal: Int J Radiat Oncol Biol Phys Date: 1998-03-01 Impact factor: 7.038
Authors: P Rousseau; J L Habrand; D Sarrazin; C Kalifa; M J Terrier-Lacombe; C Rekacewicz; A Rey Journal: Int J Radiat Oncol Biol Phys Date: 1994-01-15 Impact factor: 7.038
Authors: E Rousseau; M-M Ruchoux; F Scaravilli; F Chapon; M Vinchon; C De Smet; C Godfraind; M Vikkula Journal: Neuropathol Appl Neurobiol Date: 2003-12 Impact factor: 8.090
Authors: Kristian W Pajtler; Ji Wen; Martin Sill; Tong Lin; Wilda Orisme; Bo Tang; Jens-Martin Hübner; Vijay Ramaswamy; Sujuan Jia; James D Dalton; Kelly Haupfear; Hazel A Rogers; Chandanamali Punchihewa; Ryan Lee; John Easton; Gang Wu; Timothy A Ritzmann; Rebecca Chapman; Lukas Chavez; Fredrick A Boop; Paul Klimo; Noah D Sabin; Robert Ogg; Stephen C Mack; Brian D Freibaum; Hong Joo Kim; Hendrik Witt; David T W Jones; Baohan Vo; Amar Gajjar; Stan Pounds; Arzu Onar-Thomas; Martine F Roussel; Jinghui Zhang; J Paul Taylor; Thomas E Merchant; Richard Grundy; Ruth G Tatevossian; Michael D Taylor; Stefan M Pfister; Andrey Korshunov; Marcel Kool; David W Ellison Journal: Acta Neuropathol Date: 2018-06-16 Impact factor: 17.088
Authors: Jonas E Adolph; Gudrun Fleischhack; Ruth Mikasch; Julia Zeller; Monika Warmuth-Metz; Brigitte Bison; Martin Mynarek; Stefan Rutkowski; Ulrich Schüller; Katja von Hoff; Denise Obrecht; Torsten Pietsch; Stefan M Pfister; Kristian W Pajtler; Olaf Witt; Hendrik Witt; Rolf-Dieter Kortmann; Beate Timmermann; Jürgen Krauß; Michael C Frühwald; Andreas Faldum; Robert Kwiecien; Udo Bode; Stephan Tippelt Journal: Neuro Oncol Date: 2021-06-01 Impact factor: 12.300